Tannic Acid Attenuates Peripheral and Brain Changes in a Preclinical Rat Model of Glioblastoma by Modulating Oxidative Stress and Purinergic Signaling

• DOI: 10.1007/s11064-022-03547-7
• Publication Date: 2022-02-18T04:36:10Z
• Authors: Natália Pontes Bona; Mayara Sandrielly...; Nathalia Stark Pedra; Luiza Spohr; Francieli da Silv...; Alana Seixas de F...; Fernando Lopez Alvez; Bernardo de Morae...; Karina Pereira Lu...; Roselia Maria Spa...; Francieli Moro St...
• Keywords: 0301 basic medicine; 0303 health sciences; Adenosine; Superoxide Dismutase; Brain; Thiobarbituric Acid Reactive Substances; Adenosine Monophosphate; Antioxidants; Rats; Adenosine Diphosphate; Oxidative Stress; 03 medical and health sciences; Adenosine Triphosphate; Animals; Glioblastoma; Reactive Oxygen Species; Tannins; Nitrites

Glioblastoma (GB) is a highly aggressive and invasive brain tumor; its treatment remains palliative. Tannic acid (TA) is a polyphenol widely found in foods and possesses antitumor and neuroprotective activities. This study aimed to investigate the effect of TA on oxidative stress parameters and the activity of ectonucleotidases in the serum, platelets, and lymphocytes and/or in the brain of rats with preclinical GB. Rats with GB were treated intragastrically with TA (50 mg/kg/day) for 15 days or with a vehicle. In the platelets of the animals with glioma, the adenosine triphosphate (ATP) and adenosine monophosphate (AMP) hydrolysis and the catalase (CAT) activity decreased. Besides, the adenosine diphosphate (ADP) hydrolysis, adenosine (Ado) deamination, and the reactive oxygen species (ROS) and nitrite levels were increased in glioma animals; however, TA reversed ROS and nitrite levels and AMP hydrolysis alterations. In lymphocytes from animals with glioma, the ATP and ADP hydrolysis, as well as Ado deamination were increased; TA treatment countered this increase. In the brain of the animals with glioma, the ROS, nitrite, and thiobarbituric acid reactive substance (TBARS) levels increased and the thiol (SH) levels and CAT and superoxide dismutase (SOD) activities were decreased; TA treatment decreased the ROS and TBARS levels and restored the SOD activity. In the serum of the animals with glioma, the ATP hydrolysis decreased; TA treatment restored this parameter. Additionally, the ROS levels increased and the SH and SOD activity decreased by glioma implant; TA treatment enhanced nitrite levels and reversed SOD activity. Altogether, our results suggest that TA is an important target in the treatment of GB, as it modulates purinergic and redox systems.